NDC 70942-357-07 - Dr Butlers Hemorrhoid and Fissure PF
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 70942-357
- Requested NDC
- 70942-357-07
- Package NDCs from labels
- 70942-357-00, 70942-357-01, 70942-357-07, 70942-357-75, 70942-357-06, 70942-357-12, 70942-357-05, 70942-357-15
- Manufacturer
- Beyond Health P.A.
- Effective date
- 2026-10-22
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Dr Butler Hemorrhoid & Fissure Ointment PF | Beyond Health P.A. | 2026-10-22 | HUMAN OTC DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 70942-357-00 | Dr Butlers Hemorrhoid and Fissure PF | 28 g in 1 TUBE | OINTMENT | 28 | 5 | |
| 70942-357-01 | Dr Butlers Hemorrhoid and Fissure PF | 1 in 1 CARTON | OINTMENT | 1 | 5 | |
| 70942-357-05 | Dr Butlers Hemorrhoid and Fissure PF | 42.5 g in 1 TUBE | OINTMENT | 42.5 | 5 | |
| 70942-357-06 | Dr Butlers Hemorrhoid and Fissure PF | 2 g in 1 PACKET | OINTMENT | 2 | 5 | |
| 70942-357-07 | Dr Butlers Hemorrhoid and Fissure PF | 21.3 g in 1 TUBE | OINTMENT | 21.3 | 5 | |
| 70942-357-12 | Dr Butlers Hemorrhoid and Fissure PF | 12 in 1 CARTON | OINTMENT | 12 | 5 | |
| 70942-357-15 | Dr Butlers Hemorrhoid and Fissure PF | 1 in 1 CARTON | OINTMENT | 1 | 5 | |
| 70942-357-75 | Dr Butlers Hemorrhoid and Fissure PF | 1 in 1 CARTON | OINTMENT | 1 | 5 |
DailyMed Dashboard NDC Coverage#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 70942-357-07 | GM - Gram | 70942-357 | 33bcdb8c-dc7c-460c-88a9-a08b3eb6ecfc | 1 | 2025-11-13 |
| 70942-357-75 | GM - Gram | 70942-357 | 3b213a17-51e1-483f-ad34-8d8d9712ebff | 1 | 2025-09-12 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| NORWEX Protect Prevent Mineral Facial Sunscreen Broad Spectrum SPF30 | TITANIUM DIOXIDE, ZINC OXIDE | COSMAX USA, CORPORATION | 0d489154-6168-977e-e063-6394a90aa609 | 2024-12-26 | Warnings | SOI2LOH54Z |
| ABOVE INTIMATE LIQUIDSOAP | ABOVE INTIMATE | BASTON INDUSTRIA DE AEROSSOIS LTDA | 02f37e55-72fb-532b-e063-6394a90ab0c3 | 2024-12-26 | Warnings | V5VD430YW9 |
| Phenylephrine Hydrochloride | PHENYLEPHRINE HYDROCHLORIDE | Civica, Inc. | 7a23ed28-3912-4398-b660-bf9ec3ee3926 | 2024-12-26 | Warnings, Adverse reactions | 04JA59TNSJ |
| CITY BLOCK SHEER Oil FREE DAILY FACE PROTECTOR BROAD SPECTRUM SPF 25 | TITANIUM DIOXIDE AND ZINC OXIDE | CLINIQUE LABORATORIES LLC | ee7e2ded-b850-4e15-96a6-556111e52187 | 2024-12-25 | Warnings | SOI2LOH54Z |
| CLINIQUE SUPER DEFENSE CITY BLOCK DAILY ENERGY PLUS FACE PROTECTOR BROAD SPECTRUM SPF 50 | OCTINOXATE, TITANIUM DIOXIDE, AND ZINC OXIDE | CLINIQUE LABORATORIES LLC | d1a3d76f-16dd-4533-8144-9a3175f6e15f | 2024-12-25 | Warnings | SOI2LOH54Z |
| ORIGINS GINZING ENERGY-BOOSTING TINTED MOISTURIZER BROAD SPECTRUM SPF 40 | OCTINOXATE, OCTISALATE, OCTOCRYLENE, TITANIUM DIOXIDE, AND ZINC OXIDE | ORIGINS NATURAL RESOURCES INC. | 0fe63edf-7a49-4b33-88f1-f480f889d194 | 2024-12-25 | Warnings | SOI2LOH54Z |
| Lidocaine | LIDOCAINE | Asclemed USA, Inc. | f7ada189-7463-4bc7-83e7-f140558ecacf | 2024-12-25 | Warnings, Adverse reactions | 98PI200987 |
| Buildable Blur | HOMOSALATE, OCTISALATE, ZINC OXIDE | COSMAX USA, CORPORATION | 06b14a17-cab9-1b3e-e063-6394a90afe5d | 2024-12-25 | Warnings | SOI2LOH54Z |
| Buildable Blur | HOMOSALATE, OCTISALATE, ZINC OXIDE | COSMAX USA, CORPORATION | 06b25290-33a0-bafd-e063-6394a90a7a94 | 2024-12-25 | Warnings | SOI2LOH54Z |
| Buildable Blur | HOMOSALATE, OCTISALATE, ZINC OXIDE | COSMAX USA, CORPORATION | 06b14a17-cace-1b3e-e063-6394a90afe5d | 2024-12-25 | Warnings | SOI2LOH54Z |
| Buildable Blur | HOMOSALATE, OCTISALATE, ZINC OXIDE | COSMAX USA, CORPORATION | 06ad3c09-9f1b-b25c-e063-6294a90aebe1 | 2024-12-25 | Warnings | SOI2LOH54Z |
| Buildable Blur | HOMOSALATE, OCTISALATE, ZINC OXIDE | COSMAX USA, CORPORATION | 06c57ff5-7013-d35f-e063-6394a90a6ee2 | 2024-12-25 | Warnings | SOI2LOH54Z |
| Buildable Blur | HOMOSALATE, OCTISALATE, ZINC OXIDE | COSMAX USA, CORPORATION | 06b1f8bc-8b29-451a-e063-6294a90a34bd | 2024-12-25 | Warnings | SOI2LOH54Z |
| Buildable Blur | HOMOSALATE, OCTISALATE, ZINC OXIDE | COSMAX USA, CORPORATION | 06b26dd0-44de-91a7-e063-6394a90a603a | 2024-12-25 | Warnings | SOI2LOH54Z |
| Buildable Blur | HOMOSALATE, OCTISALATE, ZINC OXIDE | COSMAX USA, CORPORATION | 06b26dd0-44ef-91a7-e063-6394a90a603a | 2024-12-25 | Warnings | SOI2LOH54Z |
| Buildable Blur | HOMOSALATE, OCTISALATE, ZINC OXIDE | COSMAX USA, CORPORATION | 06b25290-33a3-bafd-e063-6394a90a7a94 | 2024-12-25 | Warnings | SOI2LOH54Z |
| Buildable Blur | HOMOSALATE, OCTISALATE, ZINC OXIDE | COSMAX USA, CORPORATION | 06b1f8bc-8b2b-451a-e063-6294a90a34bd | 2024-12-25 | Warnings | SOI2LOH54Z |
| Buildable Blur | HOMOSALATE, OCTISALATE, ZINC OXIDE | COSMAX USA, CORPORATION | 06b26dd0-44cb-91a7-e063-6394a90a603a | 2024-12-25 | Warnings | SOI2LOH54Z |
| Buildable Blur | HOMOSALATE, OCTISALATE, ZINC OXIDE | COSMAX USA, CORPORATION | 06b2b996-e02c-e40a-e063-6394a90aa0d9 | 2024-12-25 | Warnings | SOI2LOH54Z |
| Buildable Blur | HOMOSALATE, OCTISALATE, ZINC OXIDE | COSMAX USA, CORPORATION | 06c5efde-42e1-e4fc-e063-6394a90a491d | 2024-12-25 | Warnings | SOI2LOH54Z |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.